Clinical trial · Observational
Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)
Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study
NCT05585463CI-TRIAL-00061575ACUSAFE2021completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to demonstrate the safety of intracutaneous needles in pediatric cancer patients. For this, a two-year retrospective study will be carried out to determine the incidence of adverse effects related to acupuncture and the use of intracutaneous needles in the patient in active treatment and survivor.
Conditions
Conditions (6)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bacteremia | — | UNRESOLVED | — |
| Cancer Pediatric | Malignant Neoplasm | ALIAS | 0.85 |
| Infection;Skin;Localised | — | UNRESOLVED | — |
| Neutropenia | — | UNRESOLVED | — |
| Safety Issues | — | UNRESOLVED | — |
| Thrombocytopenia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| acupuncture | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Oncology pediatric patients treated with acupuncture
- description
- Patients in the oncology area of the Sant Joan de Déu Hospital treated at the UOPI (Integrative Pediatric Oncology Unit) from September 2019 to September 2021 have received treatment with acupuncture and intracutaneous Seirin New Pyonex Press Tack®. Patients in active treatment and survivors are included. Acupuncture treatment can be received in a hospitalization ward, an intensive care unit, a day hospital or an outpatient clinic.
- interventionNames
- Procedure: acupuncture
Primary outcomes (2)
- measure
- Incidence of local infection
- timeFrame
- From the first day of needle insertion to the fourth day (withdrawal of the intracutaneous needle)
- description
- To calculate the incidence of local infection in pediatric oncology patients during the days that the intracutaneous Seirin New Pyonex Press Tack® needles have been inserted. The result can be "yes" or "no".
- measure
- Incidence of bacteremia
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Day
- Maximum age
- 34 Years
Show eligibility criteria text
Inclusion Criteria: * Pediatric oncology patients from September 2019 to September 2021 who have received treatment with acupuncture. * Pediatric oncology patients from September 2019 to September 2021 who have received treatment with intracutaneous needles (Pyonex). Exclusion Criteria: * Pediatric oncology patients who have not received treatment with acupuncture or intracutaneous needles.
References
Publications (1)
- DERIVEDMartinez Garcia E, Jordan I, Nishishinya Aquino MB, Lopez de San Roman Fernandez C, Perez-Jaume S, Morales-La Madrid A, Fernandez-Jane C, Cruz Martinez O. Safety of Acupuncture Using Semi-Permanent Needles in a Pediatric Cancer Unit: A Retrospective Study. Integr Cancer Ther. 2026 Jan-Dec;25:15347354261439141. doi: 10.1177/15347354261439141. Epub 2026 May 19. PMID 42152774